Difference between revisions of "Small Animal Emergency and Critical Care Medicine: Self-Assessment Color Review, Second Edition, Q&A 05"
Jump to navigation
Jump to search
(Created page with "{{CRC Press}} {{Student tip |X = an example of practical application of theory. }} _ <FlashCard questions="3"> |q1= The Rule of 20 highlights coagulation as one of the importa...") |
|||
| Line 22: | Line 22: | ||
{{#tag:imagemap|Image:Next Question CRC Press.png{{!}}center{{!}}200px | {{#tag:imagemap|Image:Next Question CRC Press.png{{!}}center{{!}}200px | ||
| − | rect 0 0 860 850 [[Small Animal Emergency and Critical Care Medicine: Self-Assessment Color Review, Second Edition, | + | rect 0 0 860 850 [[Small Animal Emergency and Critical Care Medicine: Self-Assessment Color Review, Second Edition, Q&A 06|Next question]] |
desc none}} | desc none}} | ||
Revision as of 16:10, 7 November 2018
|
This question was provided by CRC Press. See more case-based flashcards |
|
Student tip: This case is an example of practical application of theory. |
_
| Question | Answer | Article | |
| The Rule of 20 highlights coagulation as one of the important aspects to monitor in SIRS patients. What is disseminated intravascular coagulation (DIC)? | DIC is characterized by systemic activation of blood coagulation resulting in generation and deposition of fibrin, leading to microvascular thrombi. Severe bleeding may occur as the coagulation proteins are depleted. However, microthrombosis can occur without excessive consumption of coagulation factors and bleeding.
|
Link to Article | |
| How is DIC diagnosed? | Diagnosis is difficult and no single routinely available laboratory test is sufficient. Diagnosis is based on presence of trauma or SIRS disease, low platelet numbers, prolonged PT/aPTT, decreased fibrinogen levels, increased fibrin degradation products, elevated D-dimers, schistocytes on blood smear, and decreased antithrombin and protein C.
|
Link to Article | |
| How is DIC treated? | Treating the underlying disease, increasing capillary blood flow, and supporting target organs are the mainstays of therapy. Replacement of coagulation proteins, +/- platelets, is done to meet patient and procedural needs. Heparin is appropriate to treat the thrombotic stage of the disease but is ineffective without sufficient antithrombin. Administration of protein C has been of benefit to subgroups of humans with sepsis.
|
Link to Article | |
To purchase the full text with your 20% off discount code, go to the CRC Press Veterinary website.
